DE60005980D1 - Benzopyran und benzothiopyran, verwendbar als selektive retinoid-agonisten - Google Patents

Benzopyran und benzothiopyran, verwendbar als selektive retinoid-agonisten

Info

Publication number
DE60005980D1
DE60005980D1 DE60005980T DE60005980T DE60005980D1 DE 60005980 D1 DE60005980 D1 DE 60005980D1 DE 60005980 T DE60005980 T DE 60005980T DE 60005980 T DE60005980 T DE 60005980T DE 60005980 D1 DE60005980 D1 DE 60005980D1
Authority
DE
Germany
Prior art keywords
benzothiopyran
benzopyran
retinoid agonists
selective retinoid
selective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60005980T
Other languages
English (en)
Other versions
DE60005980T2 (de
Inventor
Nanette Belloni
Peter Mohr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of DE60005980D1 publication Critical patent/DE60005980D1/de
Publication of DE60005980T2 publication Critical patent/DE60005980T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D313/08—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/20—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 hydrogenated in the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D337/00—Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
    • C07D337/02—Seven-membered rings
    • C07D337/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D337/08—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyrane Compounds (AREA)
DE60005980T 1999-08-25 2000-08-18 Benzopyran und benzothiopyran, verwendbar als selektive retinoid-agonisten Expired - Fee Related DE60005980T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99116603 1999-08-25
EP99116603 1999-08-25
PCT/EP2000/008065 WO2001014360A2 (en) 1999-08-25 2000-08-18 Benzopyrans and benzothiopyrans as rar selective retinoid agonists

Publications (2)

Publication Number Publication Date
DE60005980D1 true DE60005980D1 (de) 2003-11-20
DE60005980T2 DE60005980T2 (de) 2004-08-12

Family

ID=8238844

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60005980T Expired - Fee Related DE60005980T2 (de) 1999-08-25 2000-08-18 Benzopyran und benzothiopyran, verwendbar als selektive retinoid-agonisten

Country Status (18)

Country Link
US (1) US6479670B1 (de)
EP (1) EP1212316B1 (de)
JP (1) JP3795394B2 (de)
KR (1) KR100470500B1 (de)
CN (1) CN1151144C (de)
AR (1) AR025351A1 (de)
AT (1) ATE252093T1 (de)
AU (1) AU769784B2 (de)
BR (1) BR0013582A (de)
CA (1) CA2382527A1 (de)
DE (1) DE60005980T2 (de)
DK (1) DK1212316T3 (de)
ES (1) ES2207548T3 (de)
MX (1) MXPA02001939A (de)
PT (1) PT1212316E (de)
TR (1) TR200200473T2 (de)
WO (1) WO2001014360A2 (de)
ZA (1) ZA200200939B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1182195A4 (de) * 1999-05-07 2003-03-26 Takeda Chemical Industries Ltd Cyclische verbindungen und anwendungen davon
JO2178B1 (en) * 1999-10-19 2003-04-23 اف . هوفمان لاروش ايه جي Treatment of invasive diseases, using selected anti-PAR materials
EP1241166A4 (de) * 1999-12-13 2003-04-16 Chugai Pharmaceutical Co Ltd 3-mehtyl-chroman und -thiochromanderivate
JP2005518347A (ja) * 2001-11-02 2005-06-23 ジー．ディー． サール エルエルシー 頂端ナトリウム共依存性胆汁酸輸送（ａｓｂｔ）およびタウロコール酸塩取り込みの阻害剤としての新規一および二フッ化ベンゾチエピン化合物
US7101565B2 (en) 2002-02-05 2006-09-05 Corpak Medsystems, Inc. Probiotic/prebiotic composition and delivery method
AU2003286245A1 (en) * 2002-11-25 2004-06-18 Amedis Pharmaceuticals Ltd. Silicon compounds to be used as ligands for retinoid receptors
WO2005094721A1 (en) * 2004-03-30 2005-10-13 Proxy Biomedical Limited A medical device
US8415390B2 (en) 2008-05-30 2013-04-09 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
US9119777B2 (en) 2008-05-30 2015-09-01 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
EP3039126B1 (de) 2013-08-26 2019-10-09 The J. David Gladstone Institutes, A Testamentary Trust Established under The Will of J. David Gladstone Kleinmolekülige zelluläre reprogrammierung zur erzeugung neuronaler zellen
US11026932B2 (en) 2015-09-10 2021-06-08 National University Corporation Okayama University Medicinal composition for preventing or treating inflammatory respiratory disease
CN107176945B (zh) * 2016-03-11 2021-06-08 中国科学院上海有机化学研究所 一种视黄酸类化合物、其制备方法、中间体及应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5958954A (en) 1995-09-01 1999-09-28 Allergan Sales, Inc. Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities

Also Published As

Publication number Publication date
DE60005980T2 (de) 2004-08-12
ATE252093T1 (de) 2003-11-15
BR0013582A (pt) 2002-05-07
AR025351A1 (es) 2002-11-20
WO2001014360A3 (en) 2001-05-17
JP3795394B2 (ja) 2006-07-12
WO2001014360A2 (en) 2001-03-01
JP2003507465A (ja) 2003-02-25
PT1212316E (pt) 2004-02-27
CN1370156A (zh) 2002-09-18
EP1212316B1 (de) 2003-10-15
ZA200200939B (en) 2003-07-30
DK1212316T3 (da) 2004-02-23
CN1151144C (zh) 2004-05-26
CA2382527A1 (en) 2001-03-01
AU6997100A (en) 2001-03-19
EP1212316A2 (de) 2002-06-12
KR100470500B1 (ko) 2005-02-07
KR20020039335A (ko) 2002-05-25
TR200200473T2 (tr) 2002-05-21
AU769784B2 (en) 2004-02-05
US6479670B1 (en) 2002-11-12
ES2207548T3 (es) 2004-06-01
MXPA02001939A (es) 2002-08-20

Similar Documents

Publication Publication Date Title
ATE414067T1 (de) Guanidinobenzamide als mc4-r agonisten
NO995967D0 (no) Mykningsmiddelbehandlet, absorberende interlabial gjenstand
DE60218606D1 (de) Photodetektor und sein Betriebsverfahren
DE60039082D1 (de) CDMA Kodierer-Dekodierer, CDMA Nachrichtenübertragungssystem und WDM-CDMA Nachrichtenübertragungssystem
DE60239546D1 (de) Kommunikationsverfahren, kommunikationssystem und ausgabevorrichtung
DK1303509T3 (da) Beta3 adrenerge agonister
DE60221745D1 (de) Operationelle Verstärkerschaltung, Treiberschaltung und -Verfahren
AR028379A1 (es) Nuevos agonistas retinoides selectivos de rar
DE60218781D1 (de) Operationelle Verstärkerschaltung, Treiberschaltung und -Verfahren
DK1174003T3 (da) Programmerbart multimode-, multimikrofonsystem
NO20006293L (no) Nye benzopyran eller tiobenzopyranderivater
DE69927131D1 (de) Kommunikationsverfahren, -system und -vorrichtung und Server
PT1070059E (pt) Derivados de cromanona e tiocromanona
DE60214771D1 (de) Bremsvorrichtung, -anordnung und -verfahren
DE60005980D1 (de) Benzopyran und benzothiopyran, verwendbar als selektive retinoid-agonisten
DE59914471D1 (de) Chromenon- und chromanonderivate als integrinhemmer
DE60010925D1 (de) Vitamin d - analoga
DE60135518D1 (de) Überlastregelungsverfahren und -System
ATE274507T1 (de) Benzofuran- und benzothiophen-derivative als selektive cox-2 inhibitoren
PT1351959E (pt) Novos derivados de pleuromutilina
PT1140890E (pt) Derivados de cromano
DE50100383D1 (de) H-annellierte benzo [f]chromene
DE50114311D1 (de) Hub-/schwenkantrieb
DE60033231D1 (de) Personenrufanlage
DE60112230D1 (de) Kommunikationssystem, -vorrichtung und -verfahren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee